Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03447600
Other study ID # LDS-DIVA-2017
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 1, 2018
Est. completion date December 12, 2018

Study information

Verified date November 2020
Source University of Leeds
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to test the hypothesis that dietary weight loss (WL) through alternate day fasting (ADF) will enhance appetite control, health markers and wellbeing following WL compared to standard daily calorie restriction (CR).


Description:

This is a proof of concept randomized controlled trial in which overweight/obese females will be randomised to a dietary weight loss intervention (ADF or CR) to achieve ≥5% WL. Behavioural measures of appetite control including ad libitum intake after a fixed meal, body composition, resting metabolic rate, measured physical activity and daily energy expenditure, sleep quality, hedonic food reward and eating behaviour traits will be assessed before, during and after the WL intervention in those who reach the target weight loss within 12 weeks. After weight loss phase, participants will be given standard healthy eating and physical activity advice for weight maintenance and body weight will be followed up after weight loss at 12 months.


Recruitment information / eligibility

Status Completed
Enrollment 54
Est. completion date December 12, 2018
Est. primary completion date December 12, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria: - Female participants aged between 18 and 55 years at the time of signing informed consent - BMI of 25.0 - 34.9 kg/m2 Exclusion Criteria: - Significant health problems which in the opinion of the investigator, might jeopardise participant's safety or compliance with the protocol - Currently enrolled in a weight loss programme or following a specific diet plan. - History of eating disorders including binge eating. - Taking any medication or supplements known to affect appetite or weight within the past month and/or during the study - Pregnant, planning to become pregnant or breastfeeding - History of anaphylaxis to food - Known food allergies or food intolerance - Smokers and those who have recently ceased smoking (< 6 months) - BMI < 24.9 kg/m2 or > 35 kg/m2 - Volunteers having lost significant amount of weight in the previous 6 months (± 4kg) - Volunteers who exercise > 3 days per week or have significantly changed their physical activity patterns in the past 6 months or who intend to change them during the study - Participants receiving systemic or local treatment likely to interfere with evaluation of the study parameters - Participants who work in appetite or feeding related areas. - Participants who do shift work

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Alternate Day Fasting
25% daily energy requirements every other day until study completion at >/=5% weight loss which is an average of 12 weeks.
Continuous dietary restriction
25% daily energy requirements every other day until study completion at >/=5% weight loss which is an average of 12 weeks.

Locations

Country Name City State
United Kingdom University of Leeds Leeds West Yorkshire

Sponsors (2)

Lead Sponsor Collaborator
University of Leeds University of Illinois at Chicago

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in energy intake from ad libitum lunch Measured changes in ad-libitum energy intake following consumption of formulated test meal in comparison to control week 0, week 3 and at study completion, an average of 12 weeks
Secondary Change in Visual Analogue Scale (VAS) ratings of appetite Change in ratings of hunger, satiety, fullness and prospective food consumption before, after and between meals. Scale range is minimum 0 to maximum 100mm. A composite appetite score will be calculated from the average of scores on hunger, satiety, fullness and prospective food consumption scales. A higher score is considered a worse outcome. week 0, week 3 and at study completion, an average of 12 weeks
Secondary Change in Control of Eating Questionnaire (CoEQ) scale scores 21-item scale; subscales are average of relevant items; subscales are computed for dimensions of Craving Control, Craving for Savoury, Craving for Sweet, Positive Mood; minimum subscale score = 0, maximum subscale score = 100; higher values are better outcome for Craving Control and Positive Mood subscales; lower values are better outcome for Craving for Sweet and Craving for Savoury subscales. week 0, week 3 and at study completion, an average of 12 weeks
Secondary Change in explicit liking of food from Leeds Food Preference Questionnaire Leeds Food Preference Questionnaire is a computer-based task with subscales scores for the 4 food categories high fat and sweet, high fat and non-sweet, low fat and sweet and low fat and non-sweet (minimum score = 0, maximum score = 100), Higher values for high fat food categories relative to low fat food categories considered worse outcome. week 0, week 3 and at study completion, an average of 12 weeks
Secondary Change in explicit wanting of food from Leeds Food Preference Questionnaire scores Leeds Food Preference Questionnaire is a computer-based task with subscales scores for the 4 food categories high fat and sweet, high fat and non-sweet, low fat and sweet and low fat and non-sweet (minimum score = 0, maximum score = 100), Higher values for high fat food categories relative to low fat food categories considered worse outcome. week 0, week 3 and at study completion, an average of 12 weeks
Secondary Change in relative preference of food from Leeds Food Preference Questionnaire scores Leeds Food Preference Questionnaire is a computer-based task with subscales scores for the 4 food categories high fat and sweet, high fat and non-sweet, low fat and sweet and low fat and non-sweet (minimum score = 0, maximum score = 48), Higher values for high fat food categories relative to low fat food categories considered worse outcome. week 0, week 3 and at study completion, an average of 12 weeks
Secondary Change in implicit wanting of food from Leeds Food Preference Questionnaire scores Leeds Food Preference Questionnaire is a computer-based task with subscales scores for the 4 food categories high fat and sweet, high fat and non-sweet, low fat and sweet and low fat and non-sweet (minimum score = -100, maximum score = 100), Higher values for high fat food categories relative to low fat food categories considered worse outcome. week 0, week 3 and at study completion, an average of 12 weeks
Secondary Change in VAS rating of palatability post lunch Change in ratings of pleasantness, desire to eat more and palatability after the lunch test meal week 0, week 3 and at study completion, an average of 12 weeks
Secondary Change in fat mass Change in fat mass from iDXA/BodPod week 0, week 3 and at study completion, an average of 12 weeks
Secondary Change in fat free mass Change in fat free mass from iDXA/BodPod week 0, week 3 and at study completion, an average of 12 weeks
Secondary Change in resting metabolic rate Change in resting metabolic rate from indirect calorimetry week 0, week 3 and at study completion, an average of 12 weeks
Secondary Change in free-living physical activity Change in 7-day free-living physical activity from SenseWear Armband week 0, week 3 and at study completion, an average of 12 weeks
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03994419 - PErioperAtive CHildhood ObesitY
Recruiting NCT05354245 - Using a Complex Carbohydrate Mixture to Steer Fermentation and Improve Metabolism in Adults With Overweight and Prediabetes (DISTAL) N/A
Completed NCT03602001 - Attentive Eating for Weight Loss N/A
Recruiting NCT06269159 - The Power of 24-hour: Co-designing Intervention Components
Completed NCT03377244 - Healthy Body Healthy Souls in the Marshallese Population N/A
Completed NCT02996864 - Location-based Smartphone Technology to Guide College Students Healthy Choices Ph II N/A
Terminated NCT03914066 - A Group-based Treatment of Overweight and Obesity in Primary Care N/A
Completed NCT04647149 - Effects of Early and Delayed Time-restricted Eating in Adults With Overweight and Obesity N/A
Completed NCT03685656 - Effect of ANACA3 Slimming Gel on Loss of Abdominal and Thigh Circumferences in Healthy Volunteers N/A
Completed NCT05051579 - A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities Phase 2
Completed NCT04611477 - Effect of Synbiotic 365 on Body Composition in Overweight and Obese Individuals N/A
Active, not recruiting NCT05330247 - Cut Down on Carbohydrate in the Dietary Therapy of Type 2 Diabetes - The Meal Box Study N/A
Completed NCT03599115 - Effects of Inhibitory Control Training in Eating Behaviors N/A
Recruiting NCT06094231 - Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study N/A
Recruiting NCT05938894 - Train Your Brain - Executive Function N/A
Recruiting NCT05987306 - A Self-compassion Focused Intervention for Internalized Weight Bias and Weight Loss N/A
Completed NCT03792685 - Looking for Personalized Nutrition for Obesity/Type 2 Diabetes Mellitus Prevention N/A
Completed NCT05055362 - Effect a Honey, Spice-blended Baked Good Has on Salivary Inflammation Markers in Adults: a Pilot Study N/A
Completed NCT04520256 - Rapid Evaluation of Innovative Intervention Components to Maximize the Health Benefits of Behavioral Obesity Treatment Delivered Online: An Application of Multiphase Optimization Strategy Phase 2/Phase 3
Completed NCT04979234 - A Single Centre, Prospective Feasibility Study to Evaluate the Efficacy of an Endoluminal-suturing Device (Endomina) on Severe Obstructive Sleep Apnea Syndrome N/A